Salivary lysozyme and related parameters of a predominantly Chinese, HIV-infected cohort in Hong Kong

Oral Diseases

Volumn 5, Issue 3, 1999, Pages 241-246

  Tsang, C S P ^a   Samaranayake, L P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Flow rate; HIV; Hong Kong Chinese; Lysozyme; PH; Saliva

Indexed keywords

LYSOZYME; SALIVA PROTEIN;

ACIDITY; ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOUTH LESION; PRIORITY JOURNAL; PROTEIN INTERACTION; SALIVA LEVEL; SALIVATION; SUBMANDIBULAR GLAND;

EID: 0032819261     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1999.tb00308.x     Document Type: Article

References (31)

1. Atkinson JC, Yeh CK, Bermudez EZ et al (1989). Longitudinal evaluation of major salivary gland function in HIV-1 infected patients. J Oral Pathol Med 18: 469-470.
2. Atkinson JC, Yeh CK, Oppenheim FG et al (1990). Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr 3: 41-46.
3. Bahn SL (1972). Drug-related dental destruction. Oral Surg Oral Med Oral Pathol 33: 49-54.
4. Beeley JA, Chisholm DM (1976). Sarcoidosis with salivary gland involvement: biochemical studies on parotid saliva. J Lab Clin Med 88: 276-281.
5. Birkhed D, Heintze U (1989). Salivary secretion rate, buffer capacity, and pH. In: Tenovuo J, ed. Human saliva: Clinical chemistry and microbiology. Vol. I. CRC Press: Florida, pp 26-46.
6. Centers for Disease Control (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morb Mortal Wkly Rep 36: 1-15S.
7. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Human Immunodeficiency Virus (1993). Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 22: 289-291.
8. Fetter A, Partisani M, Koenig H et al (1993). Asymptomatic oral Candida albicans carriage in HIV-infection: frequency and predisposing factors. J Oral Pathol Med 22: 57-59.
9. Francis B, Green M, Payne C (1993). The GLIM system. Clarendon Press: Oxford.
10. MacFarlane TW, Mason DK (1973). Changes in the oral flora in Sjögren's syndrome. J Clin Pathol 27: 416-421.
11. Main BE, Calman KC, Ferguson MM et al (1984). The effect of cytotoxic therapy on saliva and oral flora. Oral Surg Oral Med Oral Pathol 58: 545-548.
12. Mandel ID (1980). Sialochemistry in diseases and clinical situations affecting salivary glands. Clin Lab Sci 12: 321-366.
13. Mandel ID, Barr CE, Turgeon L (1992). Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 21: 209-213.
14. Marder MZ, Barr CE, Mandel ID (1985). Cytomegalovirus presence and salivary composition in acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 60: 372-376.
15. Marquis G, Montplaisir S, Garzon S et al (1982). Fungitoxicity of muramidase, ultrastructural damage to Candida albicans. Lab Invest 46: 627-636.
16. Moutsopoulous HM, Karsh J, Wolf RO et al (1980). Lysozyme determination in parotid saliva from patients with Sjögren's syndrome. Am J Med 69: 39-42.
17. Müller F, Holberg-Peterson M, Rollag H et al (1992). Nonspecific oral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr 5: 46-51.
18. Oppenheim FG, Xu T, McMillian FM et al (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. J Biol Chem 263: 7472-7477.
19. Osserman EF, Lawlor DP (1966). Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med 124: 921-951.
20. Pollock JJ, Denepitiya L, MacKay BJ et al (1984). Fungistatic and fungicidal activity of human parotid salivary histidine rich polypeptides on Candida albicans. Infect Immun 44: 702-707.
21. Samaranayake LP (1981). Pathogenic mechanisms in oral candidosis. DDS thesis, University of Glasgow.
22. Samaranayake LP (1992). Oral mycoses in HIV infection. Oral Surg Oral Med Oral Path 73: 171-180.
23. Samaranayake LP, Calman KC, Ferguson MM et al (1984). The oral carriage of yeasts and coliforms in patients on cytotoxic therapy. J Oral Pathol Med 13: 390-393.
24. Samaranayake LP, MacFarlane TW, Lamey PJ et al (1986). A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aereus carriage in the oral cavity. J Oral Pathol Med 15: 386-388.
25. Samaranayake YH, MacFarlane TW, Samaranayake LP et al (1993). The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media. Microbios 74: 23-28.
26. Sedgley CM (1995). Enterobacteriaceae in the human oral cavity. PhD thesis, University of Hong Kong.
27. Shipman B (1979). Clinical evaluation of oral Candida in cancer chemothearpy patients. J Prosthet Dent 41: 63-67.
28. Skurk A, Krebs S, Rehberg J (1979). Flow rate, protein, amylase, lysozyme and kallikrein in human parotid saliva in health and disease. Arch Oral Biol 24: 739-743.
29. Stuchell RN, Mandel ID (1983). A comparative study of salivary lysozyme in cariesresistant and caries-susceptible adults. J Dent Res 62: 552-554.
30. Tobgi RS, Samaranayake LP, MacFarlane TW (1988). In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 3: 35-39.
31. Yeh CK, Dodds MWJ, Zuo P et al (1997). A population-based study of salivary lysozyme concentrations and candidal counts. Arch Oral Biol 1: 25-31.